Neoadjuvant chemoradiotherapy for operable esophageal cancer: Is paclitaxel necessary?

被引：0
|
作者：
Chino, J. P. [1 ]
Kelsey, C. R. [1 ]
Willett, C. G. [1 ]
Clough, R. [1 ]
Bendell, J. C. [1 ]
Hurwitz, H. I. [1 ]
D'Amico, T. [1 ]
Czito, B. G. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2147
引用
收藏
页码：S292 / S293
页数：2
相关论文
共 50 条
  • [1] Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer
    Kelsey, Chris R.
    Chino, Junzo P.
    Willett, Christopher G.
    Clough, Robert W.
    Hurwitz, Herbert I.
    Morse, Michael A.
    Bendell, Johanna C.
    D'Amico, Thomas A.
    Czito, Brian G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 770 - 776
  • [2] Neoadjuvant chemoradiotherapy for esophageal cancer - Is it worthwhile?
    Tamim, WZ
    Davidson, RS
    Quinlan, RM
    O'Shea, MA
    Orr, RK
    Swanson, RS
    ARCHIVES OF SURGERY, 1998, 133 (07) : 722 - 726
  • [3] Esophageal cancer: improved prognosis with neoadjuvant chemoradiotherapy
    Knippen, Stefan
    Duma, Marciana-Nona
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (01) : 86 - 88
  • [4] Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer
    Shridhar, Ravi
    Takahashi, Caitlin
    Huston, Jamie
    Doepker, Matthew P.
    Meredith, Kenneth L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 894 - 902
  • [5] The use of neoadjuvant chemoradiotherapy for resectable esophageal cancer
    Chidel, M
    Rice, TW
    Kupelian, PA
    Adelstein, D
    Becker, M
    RADIOLOGY, 1997, 205 : 1082 - 1082
  • [6] Neoadjuvant Chemoradiotherapy in Esophageal Cancer: Is It Still the Question?
    Pereira, Bruno
    Gourgou-Bourgade, Sophie
    Azria, David
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5133 - 5134
  • [7] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer
    Zheng, Yan
    Liu, Xianben
    Zhang, Ruixiang
    Wang, Zongfei
    Sun, Haibo
    Qin, Jianjun
    Liu, Shilei
    Li, Yin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4715 - 4723
  • [9] The effect of neoadjuvant chemoradiotherapy on physical activity in operable rectal cancer patients
    West, M. A.
    Loughney, L.
    Jack, S.
    Grocott, M. P. W.
    Walker, P.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 85 - 85
  • [10] Lymphocyte depletion after neoadjuvant chemoradiotherapy for operable gastric cancer.
    Wydmanski, Jerzy
    Chwieduk, Agata
    Kotyla, Przemyslaw
    Kaletka, Agnieszka
    Tukiendorf, Andrzej
    JOURNAL OF IMMUNOLOGY, 2015, 194
12345